Dr. Vikas Singh is a highly respected Consultant Urologist in Indore, recognized as one of the first specialists in Central India to introduce and perform the revolutionary iTind procedure for Benign Prostatic Hyperplasia (BPH). The iTind (Temporary Implantable Nitinol Device) represents a breakthrough in minimally invasive prostate treatment, offering men with moderate prostate enlargement an excellent option between medication and traditional surgery. This innovative procedure requires no cutting, no heat, and preserves sexual function while providing significant symptom relief. Performed as a simple office based procedure at Kokilaben Dhirubhai Ambani Hospital, iTind offers the unique advantage of being temporary, drug free, and highly effective with minimal side effects. Dr. Singh’s expertise ensures patients receive this cutting-edge treatment with optimal outcomes and comprehensive follow-up care. We maintain complete transparency regarding treatment costs and provide thorough insurance guidance for our patients across Central India.
Consultant Surgeon at Kokilaben Dhirubhai Ambani Hospital, Indore, offering the latest minimally invasive treatments.
Among the first specialists to bring iTind technology to Madhya Pradesh, with extensive training and experience.
Zero risk of erectile dysfunction or ejaculatory problems—ideal for sexually active men.
iTind is a temporary implant made of nitinol (a flexible metal alloy) that is placed in the prostatic urethra for 5-7 days. During this time, the device gently creates three small channels in the prostate tissue, which remain open permanently after the device is removed. This mechanical reshaping provides lasting symptom relief without destroying tissue, using heat, or requiring permanent implants.
The device consists of three struts and an anchoring leaflet that expands once positioned in the prostate. Over 5-7 days, these struts create controlled micro-channels through gentle, constant pressure. When removed, these channels remain open, improving urinary flow. The body's natural healing response maintains these pathways, providing durable symptom improvement.
iTind is particularly beneficial for men aged 45-80 with moderate BPH symptoms who haven't responded adequately to medications, want to avoid permanent implants or major surgery, are sexually active and want to preserve ejaculatory function, or prefer a drug-free solution. Prostate size between 25-75 grams is typically ideal.
The procedure takes approximately 10-15 minutes and is performed under local anesthesia in an outpatient setting. Using a specialized delivery system, Dr. Singh positions the iTind device through the urethra into the prostatic urethra. Once properly placed, the device expands to its working position. Most patients go home within an hour with the device in place.
During this period, the device works continuously to create the therapeutic channels. A temporary catheter may be placed for 1-2 days if needed. Patients can continue most normal activities with some restrictions on strenuous exercise. Mild discomfort is common but manageable with standard pain medications.
Removal is even simpler than placement, taking just 5 minutes. The device is collapsed and withdrawn through the urethra, typically with only local anesthesia or even just lubricating gel. No tissue is removed during this process. Patients typically experience immediate improvement in urinary symptoms following removal.
This innovative approach offers a unique middle ground between medication and surgery. It provides significant symptom improvement (40-50% reduction in symptom scores) with zero risk to sexual function, no permanent implants, and preservation of all future treatment options. The procedure is quick, office-based, and recovery is minimal—most men return to work within 2-3 days. Primary Advantages: Preserves ejaculation and erections, no permanent implant, minimal recovery time, drug-free solution, maintains future options.
UroLift uses permanent implants to hold prostate tissue aside. While effective and also preserving sexual function, it involves multiple permanent metal implants that remain in the body. iTind achieves similar outcomes through tissue remodeling without leaving anything behind permanently. Key Difference: Permanent vs. temporary implants.
Traditional surgical options offer excellent symptom relief but involve tissue destruction, longer recovery, and 60-80% risk of retrograde ejaculation. These are more invasive and typically reserved for larger prostates or patients who have failed less invasive options. Key Difference: Tissue destruction vs. tissue preservation.
Zero impact on erectile function or ejaculation—the most significant advantage for sexually active men.
No cutting, no burning, no tissue removal—just gentle mechanical reshaping that provides lasting relief.
Office-based procedure with return to normal activities within 2-3 days and full symptom improvement by 4-6 weeks.
Unlike other minimally invasive options, nothing remains in your body after treatment—the benefits persist without the device.
Schedule a private, confidential consultation with Dr. Singh in Indore.
iTind provides significant symptom improvement, with clinical studies showing 40-50% reduction in IPSS (prostate symptom scores) that is maintained long-term. While traditional TURP or laser surgery may offer slightly greater symptom reduction (60-70%), iTind achieves meaningful improvement without the sexual side effects, tissue destruction, or longer recovery associated with surgery. For men with moderate symptoms who want to preserve sexual function, iTind offers an excellent balance of effectiveness and safety.
No this is iTind’s most significant advantage. Clinical trials show zero risk of erectile dysfunction or retrograde ejaculation because the procedure doesn’t involve cutting nerves, removing tissue, or using heat near critical structures. Your sexual function remains completely unchanged. This makes iTind ideal for sexually active men who want symptom relief without compromising intimate health. Men concerned about fertility also benefit as ejaculatory function is fully preserved.
Most patients report minimal discomfort during both procedures. Placement is done under local anesthesia and takes only 10-15 minutes—patients describe it as similar to having a catheter placed. The 5-7 days with the device in place can involve urinary urgency, frequency, and mild discomfort, but this is manageable with standard pain medications. Removal is even simpler and quicker (5 minutes), often requiring only lubricating gel. The temporary discomfort is widely considered worthwhile given the long-term benefits and lack of sexual side effects.
During this period, you’ll go about most of your normal daily activities with some modifications. Avoid strenuous exercise, heavy lifting, and sexual activity. You may experience increased urinary frequency, urgency, and mild burning—these are signs the device is working. A temporary catheter may be placed for 1-2 days if urinary retention occurs. Most men continue working, especially desk jobs, though some prefer to take a few days off. Dr. Singh provides detailed instructions and is available for any concerns during this period.
iTind provides durable, long-lasting results. Clinical data shows sustained symptom improvement for at least 3-5 years, with many patients experiencing benefits well beyond this timeframe. Because BPH is a progressive condition, some patients may eventually need additional treatment years later as the prostate continues to enlarge with age. However, iTind preserves all future treatment options if needed years later, you can have another iTind, UroLift, medication, or even surgery. The procedure doesn’t “burn bridges” for future interventions.
iTind works best for prostate volumes between 25-75 grams—this covers most men with moderate BPH symptoms. If your prostate is larger than 75-80 grams, other options like HoLEP, ThuFLEP, or TURP may be more appropriate for achieving optimal results. Conversely, if your prostate is very small (<25 grams), your symptoms may be caused by other factors. Dr. Singh will measure your prostate size through ultrasound or MRI during evaluation and recommend the most suitable treatment based on your specific anatomy and symptom severity.
Insurance coverage for iTind varies as it’s a relatively newer technology in India. Some insurance companies cover it under their minimally invasive BPH treatment provisions, while others may require prior authorization or classify it differently. Our administrative team has experience navigating insurance approval for innovative treatments and will work with your insurance provider to maximize coverage. We also provide transparent cost estimates upfront and offer guidance on payment options if full insurance coverage isn’t available. The investment is often justified by the unique benefits of sexual function preservation and minimal recovery time.
The leading center for advanced, compassionate urological care and treatment in Indore, Madhya Pradesh.
